Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 2OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Skin Neoplasms 1Sarcoma, Kaposi 1HIV Infections 1AIDS-Related Opportunistic Infections 1

Interventions

Doxorubicin 5tecogalan 4Liposomes 4Vincristine 3Semaxinib 3Bleomycin 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2Alitretinoin 2vesnarinone 1tin etiopurpurin 1daromun 1Tumor Necrosis Factor-alpha 1Ro 24-7429 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Nelfinavir 1Molecular Diagnostic Techniques 1Mitoxantrone 1Immunotherapy 1Drug Therapy 1Daunorubicin 1Brentuximab Vedotin 1Biological Therapy 1Bexarotene 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Sarcoma, Kaposi × Nelfinavir × Clear all
NCT00002185 2005-06-24

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
20 enrolled
DermatologicSarcoma

Sarcoma, Kaposi, Skin Neoplasms, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡